Infectious Diseases Institute, Rambam Health Care Campus, Haifa, Israel.
The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.
J Clin Microbiol. 2024 Apr 10;62(4):e0170323. doi: 10.1128/jcm.01703-23. Epub 2024 Mar 12.
Serum polymerase chain reaction (PCR) for the detection of DNA has been suggested for rapid Q fever diagnosis. We evaluated the role of PCR testing in serum in the diagnosis of acute Q fever in an endemic setting. We examined patients suspected of acute Q fever tested for -specific serum real-time PCR in a tertiary hospital between January 2019 toand December 2022. In the first half, PCR orders were consultation-based by infectious diseases specialists, while in the second half, they were guided by serology, positive IgM2, and negative IgG1 and IgG2, indicating early acute infection. Logistic regression analyzed independent predictors for positive PCR. PCR positivity rates were calculated using various clinical criteria in the diagnostic algorithm. Out of 272 patients, 13 (4.8%) tested positive and 130 exhibited serologically suspected early infection. Presentation during April-July and aspartate aminotransferase (AST) > 3× upper normal limit (UNL) were independently associated with positive PCR with an odds ratio (OR) = 15.03 [95% confidence interval (CI), 1.58-142.46], = 0.018 and OR = 55.44 [95% CI, 6.16-498.69], < 0.001, respectively. PCR positivity rate was 8.5% in serologically suspected early infection vs 1.4% in other serology, yielding OR = 6.4 [95% CI, 1.4-29.7], = 0.009. Adding AST > 3× UNL increased OR to 49.5 [95% CI, 5.9-408.7], 0.001 reducing required PCR tests for a single acute Q fever case from 11.8 to 3. Elevated AST in serologically suspected early Q fever is proposed to be used in a diagnostic stewardship algorithm integrating PCR in serum in an endemic setting.
Our study suggests in a diagnostic stewardship approach the integration of molecular testing (Coxiella burnetii targeted PCR) for the diagnosis of acute Q fever in a reliable time in the endemic setting. Integrating PCR detecting in serum in routine testing of suspected early acute Q fever based on serology result increased the PCR positivity rate significantly. Adding increased transaminases optimizes PCR utility which is highly requested particularly in endemic areas.
血清聚合酶链反应(PCR)检测 DNA 已被提议用于快速 Q 热诊断。我们在地方性环境中评估了血清 PCR 检测在急性 Q 热诊断中的作用。我们在 2019 年 1 月至 2022 年 12 月期间,在一家三级医院检查了疑似急性 Q 热的患者,他们进行了针对 - 的血清实时 PCR 检测。在前半段,PCR 检测由传染病专家根据咨询意见进行,在后半段,由血清学结果(IgM2 阳性,IgG1 和 IgG2 阴性)指导,提示早期急性感染。逻辑回归分析了 PCR 阳性的独立预测因素。使用诊断算法中的各种临床标准计算 PCR 阳性率。在 272 名患者中,有 13 名(4.8%)检测呈阳性,130 名患者表现出血清学疑似早期感染。4 月至 7 月就诊和天冬氨酸氨基转移酶(AST)>3×正常值上限(UNL)与 PCR 阳性独立相关,优势比(OR)分别为 15.03(95%置信区间[CI],1.58-142.46)和 55.44(95%CI,6.16-498.69), 分别为 0.018 和 < 0.001。血清学疑似早期感染的 PCR 阳性率为 8.5%,其他血清学为 1.4%,OR 为 6.4(95%CI,1.4-29.7), = 0.009。AST>3×UNL 可将 OR 增加至 49.5(95%CI,5.9-408.7), 0.001,将单个急性 Q 热病例的 PCR 检测需求从 11.8 次降低至 3 次。在地方性环境中,建议在血清中进行血清学疑似早期 Q 热的常规检测,将聚合酶链反应(PCR)检测 Coxiella burnetii 纳入诊断管理算法中,以检测 AST 升高。
我们的研究表明,在地方性环境中,在可靠的时间内,采用分子检测(针对柯克斯体的聚合酶链反应)进行急性 Q 热诊断,这是一种诊断管理方法。根据血清学结果,在疑似急性 Q 热早期的常规检测中整合血清中 PCR 检测,可显著提高 PCR 阳性率。增加转氨酶可优化 PCR 的实用性,特别是在地方性地区,这是非常需要的。